Approval · Notice of Compliance 2047 · 1999
SEREVENT DISKUS: Notice of Compliance 2047
Issued June 29, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2047
- Date
- June 29, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New dosage form
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEREVENT DISKUS | 02231129 | Marketed |
Medicinal ingredients
- SALMETEROL XINAFOATE 50 MCG per DOSE